| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.07. | BullFrog AI Holdings, Inc.: BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026 | 1 | GlobeNewswire (USA) | ||
| 19.06. | BullFrog AI: Interview With Chairman & CEO Vin Singh About The Biotechnology Company | 1 | pulse2.com | ||
| 15.06. | BullFrog AI Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.05. | BullFrog AI Holdings, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| BULLFROG AI Aktie jetzt für 0€ handeln | |||||
| 14.05. | BullFrog AI Holdings, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 22.04. | BullFrog AI regains Nasdaq equity requirement | 2 | Seeking Alpha | ||
| 22.04. | BullFrog AI erfüllt wieder NASDAQ-Eigenkapitalanforderungen | 9 | Investing.com Deutsch | ||
| 22.04. | BullFrog AI regains Nasdaq compliance with equity rule | 1 | Investing.com | ||
| 22.04. | BullFrog AI Holdings, Inc.: BullFrog AI Regains Compliance with Nasdaq Shareholders' Equity Requirement | 204 | GlobeNewswire (Europe) | GAITHERSBURG, Md., April 22, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence ("AI") and... ► Artikel lesen | |
| 21.04. | BullFrog AI Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.04. | BullFrog AI Holdings, Inc.: BullFrog AI Announces Participation at AACR Annual Meeting | 2 | GlobeNewswire (USA) | ||
| 13.04. | BullFrog AI Holdings, Inc. - 8-K, Current Report | 13 | SEC Filings | ||
| 13.04. | BullFrog AI Holdings, Inc.: BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners | 380 | GlobeNewswire (Europe) | GAITHERSBURG, Md., April 13, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (Nasdaq: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence and machine... ► Artikel lesen | |
| 01.04. | BullFrog AI erfüllt Eigenkapitalanforderung der NASDAQ | 4 | Investing.com Deutsch | ||
| 01.04. | BullFrog AI Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 31.03. | Bullfrog AI Is Doubling on a Key Contract Win. Should You Buy the Penny Stock Here? | 7 | Barchart.com | ||
| 30.03. | Bullfrog AI stock offers a rare opportunity for investors to take profit | 7 | iNVEZZ.com | ||
| 30.03. | BullFrog AI Lands Big Pharma Deal To Crack Depression Drug Targets | 7 | Benzinga.com | ||
| 30.03. | BullFrog AI Shares Surge 126% After Commercial Agreement With Major Pharmaceutical Company | 1 | RTTNews | ||
| 30.03. | Dow Gains 200 Points; Bullfrog AI Shares Jump | 1 | Benzinga.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BB BIOTECH | 55,70 | +1,27 % | Edison Investment Research Limited: Edison issues report on BB Biotech (BION) | Edison Investment Research Limited
Edison issues report on BB Biotech (BION) 28-Jul-2026 / 14:20 GMT/BST
The issuer is solely responsible for the content of this announcement.
... ► Artikel lesen | |
| QIAGEN | 36,460 | +0,89 % | Ihre wichtigsten Termine: Frische Zahlen von Ebay, Eli Lill, Allstate, Infineon, Novo Nordisk, Walt Disney | Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine 06:45 Uhr, Deutschland: Basler... ► Artikel lesen | |
| VALNEVA | 2,291 | +0,04 % | Valneva streicht Jobs - warum die Aktie dennoch steigt | ||
| AMGEN | 355,85 | +0,13 % | Ihre wichtigsten Termine: Q2-Updates von SpaceX, Bayer, Biontech, Spotify, Pfizer, Continental, Merck & Co | © Foto: Dall-EGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine 05:00 Uhr, Großbritannien:... ► Artikel lesen | |
| NOVAVAX | 6,850 | -0,29 % | Novavax, Inc.: Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights | Reported total revenue of $57 million for the second quarter of 2026 and raised full-year 2026 Revenue Framework
Improved GAAP Combined R&D and SG&A expense... ► Artikel lesen | |
| STRYKER | 292,50 | -0,24 % | Stryker Corporation: Stryker declares an $0.88 per share quarterly dividend | Portage, Michigan, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders... ► Artikel lesen | |
| HEIDELBERG PHARMA | 2,490 | +1,22 % | Heidelberg Pharma: Was die Halbjahreszahlen über die Zukunft verraten | Bei Biotech-Unternehmen sagt eine einzelne Zahlenreihe selten alles, doch manchmal markiert sie einen Wendepunkt. Bei der Heidelberg Pharma AG (ISIN: DE000A11QVV0) könnte der Mitte Juli vorgelegte Halbjahresbericht... ► Artikel lesen | |
| ILLUMINA | 162,12 | -0,31 % | Devyser Diagnostics AB: Devyser signs first commercial reagent rental agreement under Illumina collaboration in Italy | Devyser, a global leader in advanced molecular diagnostics, today announced the first commercial agreement under its Systems Integrator collaboration with Illumina. The agreement, signed with an Italian... ► Artikel lesen | |
| CRISPR THERAPEUTICS | 46,430 | +0,32 % | CRISPR Therapeutics AG: CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results | ZUG, Switzerland and BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the second quarter ended June 30, 2026. "The second quarter reflected... ► Artikel lesen | |
| NANOREPRO | 1,975 | -0,25 % | EQS-DD: NanoRepro AG: Dr. Olaf Stiller, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
03.08.2026 / 07:15... ► Artikel lesen | |
| AAP IMPLANTATE | 1,580 | 0,00 % | EQS-HV: aap Implantate AG: Bekanntmachung der Einberufung zur Hauptversammlung am 23.06.2026 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG | EQS-News: aap Implantate AG
/ Bekanntmachung der Einberufung zur Hauptversammlung
aap Implantate AG: Bekanntmachung der Einberufung zur Hauptversammlung am 23.06.2026 in Berlin... ► Artikel lesen | |
| OCUGEN | 1,094 | -0,91 % | Ocugen Provides Business Update with Second Quarter 2026 Financial Results | Conference Call and Webcast Today at 8:30 a.m. ET Received U.S. Food and Drug Administration (FDA) clearance to initiate OCU410 Phase 3 trial for geographic atrophy (GA), secondary to dry age-related... ► Artikel lesen | |
| BIONXT SOLUTIONS | 0,207 | +5,08 % | Viking Therapeutics, BioNxt Solutions, Bausch Health - Studienerfolg entfacht neue Fantasie | Die Pharmaindustrie steht vor einer neuen Wachstumsphase. Milliarden fließen in innovative Therapien, moderne Arzneimitteltechnologien und die Weiterentwicklung etablierter Medikamente. Besonders dynamisch... ► Artikel lesen | |
| VIKING THERAPEUTICS | 29,250 | -1,35 % | Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished | ||
| INFLARX | 1,585 | -0,69 % | InflaRx N.V.: InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones | Announced advancement of izicopan in ANCA-associated vasculitis (AAV) and select renal diseases; clinical preparations ongoing as plannedInitiated feasibility assessment for broadened strategy for... ► Artikel lesen |